Abstract
It is important that population-based cancer registries provide accurate and reliable data for public health purposes. These data are essential data for planning of cancer control and prevention. In this study, we examined cancer incidence rates (year 2005–2010) in four MECC registries (Cyprus, Jordan, Israel, Izmir (Turkey)) and compared with the rates in the US. The overall age-standardized incidence rates for males were highest in the US followed by Israeli Jews, Izmir (Turkey), Cyprus, Israeli Arabs, and lowest in Jordan. In women the rates of cancer of all sites were also highest in US women followed by Israeli Jews, Cyprus, Israeli Arabs, Izmir (Turkey), and lowest in Jordan. It is of interest that although site-specific cancer rates differ between the countries studied, prostate, lung and colorectal cancers are within the five most common cancers males in all countries studied. In females, breast colorectal and endometrium cancers are three of the five most common cancers in females in all countries studied. The results presented in this paper can have implications for opportunities in cancer control and prevention in these countries. Future studies on individual cancer sites with highest rates in these Countries are currently underway.
Highlights
Cancer is one of the leading chronic diseases in the world with an estimated 14.1 million new cases and 8.2 million cancer deaths in 2012 [1]
This paper focusses on the consistency of cancer incidence rates of common cancer types in each of the four countries to examine the validity and quality of registry data in the four countries to encourage the use of the data for future cancer control and prevention programs. * Corresponding author at: Department of Epidemiology, School of Medicine, 224 Irvine Hall University of California, Irvine, CA 92697-7550, USA
Similar results were observed among females (Table 1B) with US women having the highest incidence rate, followed by Israeli Jews and Cyprus
Summary
Cancer is one of the leading chronic diseases in the world with an estimated 14.1 million new cases and 8.2 million cancer deaths in 2012 [1]. Almost 60% of these new cases and 65% of the deaths occurred in developing and low to middle income countries [1,2]. Because of this growing burden, identifying sources of accurate population-based cancer incidence data in developing Countries is an immediate public health priority to inform local policy around cancer control and prevention, to provide a way to monitor success, and to provide data for international comparison. Anton-Culver et al / Cancer Epidemiology 44 (2016) 195–202
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
